Summary
Clinical trials in rare diseases present unique challenges unseen in trials for more common conditions. Cross-border enrollment can be key to enrolling and retaining the required number of participants in a rare disease clinical trial. However this creates complex patient logistics and a regulatory maze that must be appropriately navigated. Understanding these considerations is critical to timely and successful study completion.
Register to download
Cross-Border Enrollment of Rare Disease Patients
You may also be interested in:
Page
Our Centers
Certain challenges within the drug development landscape merit a dedicatedtask force of experts and capabilities. That’s why we built our collection…
Page
Amy Raymond, PhD, Director of Therapeutic Expertise, Center for Rare Diseases
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…
Case Study
Creating Solutions to Ensure Endpoint Protection in Challenging Rare Disease Trial
The collection of high-quality endpoint data was paramount to the success of this Phase II program. Because this was the first clinical trial ever…